BLAUVELT, A.; ALONSO-LLAMAZARES, J.; BHATIA, N.; DRAELOS, Z.; DUBOIS, J.; FORMAN, S.; GOODERHAM, M.; GUENTHNER, S.; HEBERT, A.; LAIN, E.; MOORE, A.; PAPP, K.; STEIN GOLD, L.; ZIRWAS, M.; KATO, S.; SNYDER, S.; KRUPA, D.; BURNETT, P.; BERK, D.; CHU, D. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s196, 2023. DOI: 10.25251/skin.7.supp.196. Disponível em: https://dermsquared.com/skin/article/view/2037. Acesso em: 20 sep. 2024.